SCHEMBL30865068

SCHEMBL30865068

CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C

nearest known ligand 0.58

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 1/20 0.58
▸ NPY4R P50391 11/20 0.54
▸ NPY1R P25929 7/20 0.54
▸ IL23R Q5VWK5 6/20 0.54
▸ NPY2R P49146 5/20 0.54
▸ NPY5R Q15761 5/20 0.54
▸ OPRM1 P35372 1/20 0.53
▸ OPRD1 P41143 1/20 0.53
▸ OPRK1 P41145 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30184327 0.99 TFPI (0.60) TFPINPY4RNPY1RIL23RNPY2R
SCHEMBL30865075 0.99 TFPI (0.60) TFPINPY4RNPY1RIL23RNPY2R
SCHEMBL30865071 0.94 TFPI (0.61) TFPINPY4RNPY1RIL23RNPY2R
SCHEMBL30184264 0.94 TFPI (0.62) TFPINPY4RNPY1RNPY2RNPY5R
SCHEMBL12359225 0.93 TFPI (0.61) TFPIIL23R
SCHEMBL13912288 0.93 TFPI (0.61) TFPIIL23R
SCHEMBL16015184 0.93 TFPI (0.61) TFPIIL23R
SCHEMBL2881677 0.93 TFPI (0.61) TFPIIL23R
SCHEMBL13342836 0.93 TFPI (0.61) TFPIIL23R
SCHEMBL13324659 0.93 TFPI (0.61) TFPIIL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240041986-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF TYPE 1 DIABETES DR. MARY MORRIS & ASSOCIATES, LLC (US) 2024-02-08 — — US disclosed
Send feedback